Ambar, G. and Chiavegatto, S.. (2009). “Anabolic-androgenic steroid treatment induces behavioral disinhibition and downregulation of serotonin receptor messenger RNA in the prefrontal cortex and amygdala of male mice.” Genes Brain Behav, 8, 161–173.Google Scholar

Andersen, M. B., Werge, T., and Fink-Jensen, A.. (2007). “The acetylcholinesterase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys.” J Pharmacol Exp Ther, 321, 1179–1182.CrossRefGoogle ScholarPubMed

Benus, R. F., Bohus, B., Koolhaas, J. M., et al. (1991). “Heritable variation for aggression as a reflection of individual coping strategies.” Experientia, 47, 1008–1019.CrossRefGoogle ScholarPubMed

Bethea, C. L., Phu, K., Kim, A., et al. (2015). “Androgen metabolites impact CSF amines and axonal serotonin via MAO-A and -B in male macaques.” Neuroscience, 301, 576–589.Google Scholar

Bosboom, J. L., Stoffers, D., and Wolters, E.. (2003). “The role of acetylcholine and dopamine in dementia and psychosis in Parkinson’s disease.” J Neural Transm Suppl, 185–195.CrossRefGoogle Scholar

Bosch, O. J., Dabrowska, J., Modi, M. E., et al. (2016). “Oxytocin in the nucleus accumbens shell reverses CRFR2-evoked passive stress-coping after partner loss in monogamous male prairie voles.” Psychoneuroendocrinology, 64, 66–78.CrossRefGoogle ScholarPubMed

Brunner, H. G., Nelen, M., Breakefield, X. O., et al. (1993). “Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A.” Science, 262, 578–580.CrossRefGoogle ScholarPubMed

Buades-Rotger, M. and Gallardo-Pujol, D.. (2014). “The role of the monoamine oxidase A gene in moderating the response to adversity and associated antisocial behavior: a review.” Psychol Res Behav Manag, 7, 185–200.Google Scholar

de Almeida, R. M., Ferrari, P. F., Parmigiani, S., et al. (2005). “Escalated aggressive behavior: dopamine, serotonin and GABA.” Eur J Pharmacol, 526, 51–64.Google Scholar

de Boer, S. F., van der Vegt, B. J. and Koolhaas, J. M.. (2003). “Individual variation in aggression of feral rodent strains: a standard for the genetics of aggression and violence?” Behav Genet, 33, 485–501.Google Scholar

de Wied, D., Diamant, M., and Fodor, M.. (1993). “Central nervous system effects of the neurohypophyseal hormones and related peptides.” Front Neuroendocrinol, 14, 251–302.Google Scholar

DeLong, M. R. and Wichmann, T.. (2007). “Circuits and circuit disorders of the basal ganglia.” Arch Neurol, 64, 20–24.Google Scholar

Di Chiara, G., Bassareo, V., Fenu, S., et al. (2004). “Dopamine and drug addiction: the nucleus accumbens shell connection.” Neuropharmacology, 47 Suppl 1, 227–241.Google Scholar

Eme, R. (2010). “Male life-course-persistent antisocial behavior: the most important pediatric mental health problem.” Arch Pediatr Adolesc Med, 164, 486–487.Google Scholar

Fava, M., Johe, K., Ereshefsky, L., et al. (2015). “A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.” Mol Psychiatry.Google Scholar

Gallagher, D. and Herrmann, N.. (2014). “Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy?” Drugs, 74, 1747–1755.Google Scholar

Haney, M. (2005). “The marijuana withdrawal syndrome: diagnosis and treatment.” Curr Psychiatry Rep, 7, 360–366.Google Scholar

Hardy, J., Cowburn, R., Barton, A., et al. (1987). “Region-specific loss of glutamate innervation in Alzheimer’s disease.” Neurosci Lett, 73, 77–80.Google Scholar

Herrmann, N., Cappell, J., Eryavec, G. M., et al. (2011). “Changes in nursing burden following memantine for agitation and aggression in long-term care residents with moderate to severe Alzheimer’s disease: an open-label pilot study.” CNS Drugs, 25, 425–433.Google Scholar

Hirota, T., Veenstra-Vanderweele, J., Hollander, E., et al. (2014). “Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis.” J Autism Dev Disord, 44, 948–957.Google Scholar

Hshieh, T. T., Fong, T. G., Marcantonio, E. R., et al. (2008). “Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence.” J Gerontol A Biol Sci Med Sci, 63, 764–772.Google Scholar

Kiecolt-Glaser, J. K., Derry, H. M., and Fagundes, C. P.. (2015). “Inflammation: depression fans the flames and feasts on the heat.” Am J Psychiatry, 172, 1075–1091.Google Scholar

Kim, I. H., Rossi, M. A., Aryal, D. K., et al. (2015). “Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine.” Nat Neurosci, 18, 883–891.Google Scholar

Kirby, M. and Lawlor, B. A.. (1995). “Biologic markers and neurochemical correlates of agitation and psychosis in dementia.” J Geriatr Psychiatry Neurol, 8 Suppl 1, S2–7.CrossRefGoogle ScholarPubMed

Kumsta, R. and Heinrichs, M.. (2013). “Oxytocin, stress and social behavior: neurogenetics of the human oxytocin system.” Curr Opin Neurobiol, 23, 11–16.Google Scholar

Kumsta, R., Hummel, E., Chen, F. S., et al. (2013). “Epigenetic regulation of the oxytocin receptor gene: implications for behavioral neuroscience.” Front Neurosci, 7, 83.CrossRefGoogle ScholarPubMed

Li, J. J. and Lee, S. S.. (2010). “Latent class analysis of antisocial behavior: interaction of serotonin transporter genotype and maltreatment.” J Abnorm Child Psychol, 38, 789–801.Google Scholar

Liechti, M. (2015). “Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.” Swiss Med Wkly, 145, w14043.Google ScholarPubMed

Lindenmayer, J. P. (2000). “The pathophysiology of agitation.” J Clin Psychiatry, 61 Suppl 14, 5–10.Google Scholar

Liu, C. S., Chau, S. A., Ruthirakuhan, M., et al. (2015). “Cannabinoids for the treatment of agitation and aggression in Alzheimer’s disease.” CNS Drugs, 29, 615–623.CrossRefGoogle ScholarPubMed

Maes, M., Scharpe, S., Verkerk, R., et al. (1995). “Seasonal variation in plasma L-tryptophan availability in healthy volunteers: relationships to violent suicide occurrence.” Arch Gen Psychiatry, 52, 937–946.Google Scholar

Maneta, E. and Garcia, G.. (2014). “Psychiatric manifestations of Anti-NMDA receptor encephalitis: neurobiological underpinnings and differential diagnostic implications.” Psychosomatics, 55, 37–44.Google Scholar

Meldrum, B. S. (2000). “Glutamate as a neurotransmitter in the brain: review of physiology and pathology.” J Nutr, 130, 1007S–1015S.Google Scholar

Miczek, K. A., Fish, E. W., De Bold, J. F., et al. (2002). “Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.” Psychopharmacology (Berl), 163, 434–458.Google Scholar

Myers, A. J., Williams, L., Gatt, J. M., et al. (2014). “Variation in the oxytocin receptor gene is associated with increased risk for anxiety, stress and depression in individuals with a history of exposure to early life stress.” J Psychiatr Res, 59, 93–100.Google Scholar

Nichols, C. D. and Sanders-Bush, E.. (2004). “Molecular genetic responses to lysergic acid diethylamide include transcriptional activation of MAP kinase phosphatase-1, C/EBP-beta and ILAD-1, a novel gene with homology to arrestins.” J Neurochem, 90, 576–584.Google Scholar

O’Driscoll, K. and Leach, J. P.. (1998). “‘No longer Gage’: an iron bar through the head. Early observations of personality change after injury to the prefrontal cortex.” BMJ, 317, 1673–1674.Google Scholar

Picciotto, M. R., Lewis, A. S., van Schalkwyk, G. I., et al. (2015). “Mood and anxiety regulation by nicotinic acetylcholine receptors: a potential pathway to modulate aggression and related behavioral states.” Neuropharmacology, 96, 235–243.Google Scholar

Porsteinsson, A. P., Keltz, M. A. and Smith, J. S.. (2014). “Role of citalopram in the treatment of agitation in Alzheimer’s disease.” Neurodegener Dis Manag, 4, 345–349.Google Scholar

Radley, J. J., Kabbaj, M., Jacobson, L., et al. (2011). “Stress risk factors and stress-related pathology: neuroplasticity, epigenetics and endophenotypes.” Stress, 14, 481–497.Google Scholar

Ramirez, B. G., Blazquez, C., Gomez del Pulgar, T., et al. (2005). “Prevention of Alzheimer’s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.” J Neurosci, 25, 1904–1913.Google Scholar

Sachdev, P. and Kruk, J.. (1996). “Restlessness: the anatomy of a neuropsychiatric symptom.” Aust N Z J Psychiatry, 30, 38–53.Google Scholar

Sachdev, P. S., Chen, X., Joscelyne, A., et al. (2007). “Amygdala in stroke/transient ischemic attack patients and its relationship to cognitive impairment and psychopathology: the Sydney Stroke Study.” Am J Geriatr Psychiatry, 15, 487–496.Google Scholar

Shibuya-Tayoshi, S., Tsuchiya, K., Seki, Y., et al. (2005). “Presenile dementia mimicking Pick’s disease: an autopsy case of localized amygdala degeneration with character change and emotional disorder.” Neuropathology, 25, 235–240.Google Scholar

Siegel, A. and Victoroff, J.. (2009). “Understanding human aggression: new insights from neuroscience.” Int J Law Psychiatry, 32, 209–215.Google Scholar

Siegel, J. Z. and Crockett, M. J.. (2013). “How serotonin shapes moral judgment and behavior.” Ann N Y Acad Sci, 1299, 42–51.Google Scholar

Siepmann, T., Penzlin, A. I., Kepplinger, J., et al. (2015). “Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence.” Brain Behav, 5, e00373.Google Scholar

Smith, C. C., Gibbs, T. T., and Farb, D. H.. (2014). “Pregnenolone sulfate as a modulator of synaptic plasticity.” Psychopharmacology (Berl), 231, 3537–3556.Google Scholar

Taft, C. T., Creech, S. K., and Kachadourian, L.. (2012). “Assessment and treatment of posttraumatic anger and aggression: a review.” J Rehabil Res Dev, 49, 777–788.Google Scholar

Takahashi, A., Shiroishi, T., and Koide, T.. (2014). “Genetic mapping of escalated aggression in wild-derived mouse strain MSM/Ms: association with serotonin-related genes.” Front Neurosci, 8, 156.Google Scholar

Takahashi, A., Sugimoto, H., Kato, S., et al. (2015). “Mapping of genetic factors that elicit intermale aggressive behavior on mouse chromosome 15: intruder effects and the complex genetic basis.” PLoS One, 10, e0137764.Google Scholar

Terracciano, A., Esko, T., Sutin, A. R., et al. (2011). “Meta-analysis of genome-wide association studies identifies common variants in CTNNA2 associated with excitement-seeking.” Transl Psychiatry, 1, e49.Google Scholar

Trzepacz, P. T., Yu, P., Bhamidipati, P. K., et al. (2013). “Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer’s disease.” Alzheimers Dement, 9, S95–S104 e101.Google Scholar

Van den Elsen, G. A., Ahmed, A. I., Verkes, R. J., et al. (2015). “Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: a randomized controlled trial.” Neurology, 84, 2338–2346.Google Scholar

Van der Jeugd, A., Blum, D., Raison, S., et al. (2013). “Observations in THY-Tau22 mice that resemble behavioral and psychological signs and symptoms of dementia.” Behav Brain Res, 242, 34–39.Google Scholar

Van der Mast, R. C. and Fekkes, D.. (2000). “Serotonin and amino acids: partners in delirium pathophysiology?” Semin Clin Neuropsychiatry, 5, 125–131.Google Scholar

Volk, D. W., Chitrapu, A., Edelson, J. R., et al. (2015). “Molecular mechanisms and timing of cortical immune activation in schizophrenia.” Am J Psychiatry, 172, 1112–1121.Google Scholar

Waters, E., Morrall, M. C. and Murdoch-Eaton, D.. (2010). “Archimedes. Question 3. Should carbamazepine be administered to manage agitation and aggressive behaviour following paediatric acquired brain injury?” Arch Dis Child, 95, 950–952.Google Scholar

Wilkinson, S. T., Stefanovics, E. and Rosenheck, R. A.. (2015). “Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with posttraumatic stress disorder.” J Clin Psychiatry, 76, 1174–1180.Google Scholar

Wong, P., Chang, C. C., Marx, C. E., et al. (2012). “Pregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice.” PLoS One, 7, e51455.Google Scholar

Zalcman, S. S. and Siegel, A.. (2006). “The neurobiology of aggression and rage: role of cytokines.” Brain Behav Immun, 20, 507–514.Google Scholar

Zhang, Y., Traskman-Bendz, L., Janelidze, S., et al. (2012). “Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence.” J Clin Psychiatry, 73, 1069–1076.Google Scholar

Ziv, L., Muto, A., Schoonheim, P. J., et al. (2013). “An affective disorder in zebrafish with mutation of the glucocorticoid receptor.” Mol Psychiatry, 18, 681–691.Google Scholar